Physician profile
Meredith Wall
NPI 1497475008
$1,795.99
in general payments reported to CMS, 2019-2025
20 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $44.26 · 2023: $641 · 2024: $872 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,687 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,686.74 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $217.95 | 2023-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $194.97 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $181.96 | 2023-2024 | Xarelto |
| Pfizer INC. | $176.11 | 2023-2024 | |
| Actelion Pharmaceuticals US, INC. | $147.83 | 2023 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $127.66 | 2023-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.70 | 2022-2025 | Jardiance |
| Boston Scientific Corporation | $104.88 | 2023-2024 | Watchman Access System |
| Amgen INC. | $92.90 | 2022-2024 | Repatha |
| Novo Nordisk INC | $79.10 | 2023-2024 | Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $56.09 | 2023-2024 | Lifevest |
| Scpharmaceuticals INC. | $50.45 | 2023-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $50.02 | 2024 | Arcalyst |
| Cardiva Medical, INC. | $44.34 | 2023 | Cardiva Vascade 6/7f Vcs |
| Sanofi US Services INC. | $36.19 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $34.80 | 2024-2025 | Nexletol |
| Medtronic, INC. | $24.17 | 2023 | Symplicity G3 |
| Irhythm Technologies, INC. | $23.24 | 2023 | Zio Xt Patch |
| Abiomed | $23.02 | 2024 | Impella |
| Astrazeneca Pharmaceuticals LP | $21.61 | 2025 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Wall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.